162.37 USD
↘ 1.41 (0.86%)LIVE (AS OF 10:13 AM EDT)
Shares of AstraZeneca PLC (AZN) are trading at $162.37. AZN shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bullish Golden Cross on the moving averages. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 14, 2026.
Open?$161.42
High?$163.40
Low?$160.76
Prev. Close?$163.78
Volume?574.8K
Avg. Volume?4.0M
VWAP?$161.56
Rel. Volume?0.14x
Bid / Ask
Bid?$161.61 × 100
Ask?$161.67 × 100
Spread?$0.06
Midpoint?$161.64
Valuation & Ratios
Market Cap?254.0B
Shares Out?N/A
P/E Ratio?114.37
P/B Ratio?18.77
EPS?$1.43
Dividend?1.39%
Ex-Dividend?N/A
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Themes
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?96
Momentum?6
Short Sent.?63
Piotroski F-Score?2/9Weak
Altman Z-Score?4.50Safe
Confidence?58%Low
Short InterestLow
Short Interest?2.9M
Days to Cover?1.0
Avg Daily Volume3.3M
Settlement Date2026-08-31
Financial Health
Current Ratio?0.93Weak
Quick Ratio?0.76Weak
Cash Ratio?0.27Low
Debt/Equity?1.40Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?114.4PRICEY▾
Peers11
S&P3
P/B?18.77HIGH▾
Peers22
S&P8
P/S?10.56HIGH▾
Peers27
S&P7
P/FCF?111.7PRICEY▾
Peers11
S&P3
EV/EBITDA?50.5HIGH▾
Peers11
S&P3
EV/Sales?11.18HIGH▾
Peers27
S&P9
Returns & Efficiency
ROE?16.4%STRONG▾
Peers44
S&P58
ROA?3.5%FAIR▾
Peers44
S&P31
Cash Flow & Enterprise
FCF?$2.3B
Enterprise Value?$269.1B
Fundamentals ratios updated end of day